🇺🇸 FDA
Patent

US 10683316

Synthetic catalase/superoxide dismutase mimetics and methods for treating viral infections

granted A61PA61P31/12

Quick answer

US patent 10683316 (Synthetic catalase/superoxide dismutase mimetics and methods for treating viral infections) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P31/12